Burlington Stores Inc
For the period ended Aug 3, 2024. Filed Aug 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Aug 3, 2024 · Filed Aug 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
August 3, 2024
- Summary of Significant Accounting Policies
Basis of Presentation
As of August 3, 2024, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 1,057 retail stores.
These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated
Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024 (Fiscal 2023 10-K). The balance sheet at February 3, 2024 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2023 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and six month periods ended August 3, 2024 are not necessarily indicative of results for the fiscal year.
Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2023 10-K.
Fiscal Year
The Company defines its fiscal year as the 52 or 53-week period ending on the Saturday closest to January 31. Fiscal 2024 is defined as the 52-week year ending February 1, 2025, and Fiscal 2023 is defined as the 53-week year ended February 3, 2024. The first and second quarters of Fiscal 2024 and Fiscal 2023 each consist of 13 weeks.
Recently Adopted Accounting Standards
There were no new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and six month periods ended August 3, 2024.
In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" (ASU 2023-09) to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and canbe applied on either a prospective or retroactive basis. We are currently determining the impact that ASU 2023-09 will have on the Company's consolidated financial statement disclosures
- Stockholders’ Equity
Activity forthe three and six month periods ended August 3, 2024 and July 29, 2023 in the Company’s stockholders’ equity is summarized below:
| (in thousands, except share data) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-in · Accumulated · AccumulatedOtherComprehensive · Treasury Stock | ||||||||
| Shares | Amount | Capital | Earnings | Income | Shares | Amount | Total | |
| Balance at February 3, 2024 | 82,399,577 | $8 | $2,118,356 | $984,064 | $33,533 | (18,435,206) | $(2,139,029) | $996,932 |
| Net income | — | — | — | 78,514 | — | — | — | 78,514 |
| Stock options exercised | 55,688 | — | 8,472 | — | — | — | — | 8,472 |
| Shares used for tax withholding | — | — | — | — | — | (63,407) | (12,222) | (12,222) |
| Shares purchased as part of publicly announced program, inclusive of $0.4 million related to excise tax | — | — | — | — | — | (312,238) | (63,769) | (63,769) |
| Vesting of restricted shares | 181,607 | — | — | — | — | — | — | — |
| Stock based compensation | — | — | 19,107 | — | — | — | — | 19,107 |
| Unrealized gains on interest rate derivative contracts, net of related taxes of $2.8 million | — | — | — | — | 7,735 | — | — | 7,735 |
| Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $1.2 million | — | — | — | — | (3,343) | — | — | (3,343) |
| Balance at May 4, 2024 | 82,636,872 | 8 | 2,145,935 | 1,062,578 | 37,925 | (18,810,851) | (2,215,020) | 1,031,426 |
| Net income | — | — | — | 73,760 | — | — | — | 73,760 |
| Stock options exercised | 89,961 | — | 15,393 | — | — | — | — | 15,393 |
| Shares used for tax withholding | — | — | — | — | — | (3,790) | (916) | (916) |
| Shares purchased as part of publicly announced program, inclusive of $0.5 million related to excise tax | — | — | — | — | — | (269,508) | (61,721) | (61,721) |
| Vesting of restricted shares | 19,674 | — | — | — | — | — | — | — |
| Stock based compensation | — | — | 24,779 | — | — | — | — | 24,779 |
| Unrealized losses on interest rate derivative contracts, net of related taxes of $3.3 million | — | — | — | — | (9,037) | — | — | (9,037) |
| Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $1.2 million | — | — | — | — | (3,347) | — | — | (3,347) |
| Balance at August 3, 2024 | 82,746,507 | $8 | $2,186,107 | $1,136,338 | $25,541 | (19,084,149) | $(2,277,657) | $1,070,337 |
| (in thousands, except share data) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-in · Accumulated (Deficit) · AccumulatedOtherComprehensive · Treasury Stock | ||||||||
| Shares | Amount | Capital | Earnings | (Loss) Income | Shares | Amount | Total | |
| Balance at January 28, 2023 | 82,037,994 | $8 | $2,015,625 | $644,415 | $28,748 | (17,018,281) | $(1,893,891) | $794,905 |
| Net income | — | — | — | 32,748 | — | — | — | 32,748 |
| Stock options exercised | 90,971 | — | 10,764 | — | — | — | — | 10,764 |
| Shares used for tax withholding | — | — | — | — | — | (9,457) | (1,962) | (1,962) |
| Shares purchased as part of publicly announced program, inclusive of $0.4 million related to excise tax | — | — | — | — | — | (245,414) | (51,823) | (51,823) |
| Vesting of restricted shares | 28,536 | — | — | — | — | — | — | — |
| Stock based compensation | — | — | 16,722 | — | — | — | — | 16,722 |
| Unrealized gains on interest rate derivative contracts, net of related taxes of $0.3 million | — | — | — | — | 947 | — | — | 947 |
| Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $0.3 million | — | — | — | — | (827) | — | — | (827) |
| Balance at April 29, 2023 | 82,157,501 | 8 | 2,043,111 | 677,163 | 28,868 | (17,273,152) | (1,947,676) | 801,474 |
| Net income | — | — | — | 30,892 | — | — | — | 30,892 |
| Stock options exercised | 15,236 | — | 1,512 | — | — | — | — | 1,512 |
| Shares used for tax withholding | — | — | — | — | — | (48,938) | (8,626) | (8,626) |
| Shares purchased as part of publicly announced program, inclusive of $0.1 million related to excise tax | — | — | — | — | — | (154,358) | (26,104) | (26,104) |
| Vesting of restricted shares | 153,739 | — | — | — | — | — | — | — |
| Stock based compensation | — | — | 19,425 | — | — | — | — | 19,425 |
| Unrealized gains on interest rate derivative contracts, net of related taxes of $3.1 million | — | — | — | — | 8,465 | — | — | 8,465 |
| Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $0.4 million | — | — | — | — | (1,179) | — | — | (1,179) |
| Balance at July 29, 2023 | 82,326,476 | $8 | $2,064,048 | $708,055 | $36,154 | (17,476,448) | $(1,982,406) | $825,859 |
- Lease Commitments
The Company’s leases primarily consist of stores, distribution facilities and office space under operating and finance leases that will expire principally during the next 30 years. The leases typically include renewal options atfive-year intervals and escalation clauses. Lease renewals are only included in the lease liability to the extent that they are reasonably assured of being exercised. The Company’s leases typically provide for contingent rentals based on a percentage of gross sales. Contingent rentals are not included in the lease liability, and they are recognized as variable lease cost when incurred.
The following is a schedule of the Company’s future lease payments:
| (in thousands) | ||||
|---|---|---|---|---|
| Fiscal Year · OperatingLeases · FinanceLeases | ||||
| 2024 (remainder) | $256,021 | $1,737 | ||
| 2025 | 635,498 | 3,526 | ||
| 2026 | 595,703 | 3,640 | ||
| 2027 | 553,437 | 3,640 | ||
| 2028 | 505,187 | 3,447 | ||
| Thereafter | 1,767,772 | 20,787 | ||
| Total future minimum lease payments | 4,313,618 | 36,777 | ||
| Amount representing interest | (904,212) | (10,754) | ||
| Total lease liabilities | 3,409,406 | 26,023 | ||
| Less: current portion of lease liabilities | (388,849) | (2,123) | ||
| Total long term lease liabilities | $3,020,557 | $23,900 | ||
| Weighted average discount rate | 5.9% | 5.5.% | ||
| Weighted average remaining lease term (years) | 7.9 | 12.4 | ||
The above schedule excludes approximately $609.4 million for 68 stores and one distribution center that the Company has committed to open or relocate but has not yet taken possession of the space. The discount rates used in valuing the Company’s leases are not readily determinable, and are based on the Company’s incremental borrowing rate on a fully collateralized basis.
The Company has entered into a lease agreement for a new distribution center in Ellabell, GA, which is expected to commence in Spring 2025. The Company does not have control of the asset during construction, but it is involved in the design and construction of the related asset. Additionally, the lease agreement has a purchase option, which can be exercised beginning after the earlier of (a) substantial completion of construction or (b) the date the Company commences business operations in the premises.
The following is a schedule of net lease costs for the periods indicated:
| (in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Six Months Ended | |||
| August 3, 2024 | July 29, 2023 | August 3, 2024 | July 29, 2023 | |
| Finance lease cost: | ||||
| Amortization of finance lease asset (a) | $643 | $877 | $1,442 | $1,753 |
| Interest on lease liabilities (b) | 362 | 475 | 745 | 971 |
| Operating lease cost (c) | 156,848 | 140,852 | 308,028 | 279,802 |
| Variable lease cost (c) | 61,596 | 55,878 | 122,552 | 109,949 |
| Total lease cost | 219,449 | 198,082 | 432,767 | 392,475 |
| Impairment (gain) on sale and leaseback transaction (d) | — | — | 8,210 | (1,958) |
| Less all rental income (e) | (1,334) | (1,442) | (2,713) | (2,840) |
| Total net rent expense (f) | $218,115 | $196,640 | $438,264 | $387,677 |
(a)
Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income.
(b)
Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income.
(c)
Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income.
(d)
Impairment included in the line item "Impairment charges - long-lived assets" and gain included in line item “Other income - net” in the Company’s Condensed Consolidated Statements of Income.
(e)
Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income.
(f)
Excludes an immaterial amount of short-term lease cost.
Supplemental cash flow disclosures related to leases are as follows:
| (in thousands) | ||
|---|---|---|
| Six Months Ended | ||
| August 3, 2024 | July 29, 2023 | |
| Cash paid for amounts included in the measurement of lease liabilities: | ||
| Cash payments arising from operating lease liabilities (a) | $311,147 | $282,825 |
| Cash payments for the principal portion of finance lease liabilities (b) | $1,523 | $1,952 |
| Cash payments for the interest portion of finance lease liabilities (a) | $745 | $971 |
| Supplemental non-cash information: | ||
| Operating lease liabilities arising from obtaining right-of-use assets | $305,936 | $188,878 |
(a)
Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows.
(b)
Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.
- Long Term Debt
Long term debt consists of:
| (in thousands) | |||
|---|---|---|---|
| August 3, | February 3, | July 29, | |
| 2024 | 2024 | 2023 | |
| Senior secured term loan facility (Term B-6 Loans), adjusted SOFR (with a floor of 0.00%) plus 2.00%, matures on June 24, 2028 | $929,014 | $933,355 | $937,676 |
| Convertible senior notes, 2.25%, mature on April 15, 2025 | 156,155 | 156,155 | 397,375 |
| Convertible senior notes, 1.25%, mature on December 15, 2027 | 297,069 | 297,069 | — |
| ABL senior secured revolving facility, SOFR plus spread based on average outstanding balance, matures on December 22, 2026 | — | — | — |
| Finance lease obligations | 26,023 | 29,069 | 31,495 |
| Unamortized deferred financing costs | (5,848) | (7,003) | (4,952) |
| Total debt | 1,402,413 | 1,408,645 | 1,361,594 |
| Less: current maturities | (167,892) | (13,703) | (13,867) |
| Long term debt, net of current maturities | $1,234,521 | $1,394,942 | $1,347,727 |
Term Loan Facility
BCFWC and certain of its subsidiaries and holding companies are party to a Credit Agreement (as amended, supplemented and otherwise modified, the Term Loan Facility) that provides for term loans in an aggregate principal amount as of August 3, 2024 of $932.6 million maturing on June 24, 2028.
The Term Loan Facility is collateralized by a first lien on BCFWC’s and each guarantor’s equity interests, equipment, intellectual property, and certain favorable leases and real estate, and certain related assets and proceeds thereof (subject to certain exceptions), and a second lien on BCFWC’s and each guarantor’s other assets and proceeds thereof (subject to certain exceptions). On May 11, 2023, the Company amended the Term Loan Credit Agreement to, effective as of June 30, 2023, change one of the reference interest rates for borrowings under the Term Loan Facility from the Term Loan Adjusted LIBOR Rate to the Adjusted Term Secured Overnight Financing Rate (SOFR) Rate (as defined in the Term Loan Credit Agreement). The Adjusted Term SOFR Rate includes a credit spread adjustment of 0.11% for an interest period of one-month’s duration,0.26% for an interest period of three-months’ duration and 0.43% for an interest period of six-months’ duration, with a floor of 0.00%.
Interest rates for the Term Loan Facility are based on: (i) for SOFR loans, a rate per annum equal to the Adjusted Term SOFR Rate for the applicable interest period, plus a margin of 2.00%; and (ii) for prime rate loans, a rate per annum equal to the highest of (a) the variable annual rate of interest then announced by JPMorgan Chase Bank, N.A. at its head office as its “prime rate,” (b) the federal reserve bank of New York rate in effect on such date plus 0.50% per annum, and (c) the Adjusted Term SOFR Rate for the applicable class of term loans for one-month plus 1.00%, plus, in each case, a margin of 1.00%.
At August 3, 2024 and July 29, 2023, the interest rate related to the Term Loan Facility was 7.5% and 7.4%, respectively.
2025 Convertible Notes
On April 16, 2020, the Company issued $805.0 million of its 2.25% Convertible Senior Notes due 2025 (2025 Convertible Notes). The 2025 Convertible Notes are general unsecured obligations of the Company. The 2025 Convertible Notes bear interest at a rate of 2.25% per year, payable semi-annually in cash, in arrears, on April 15 and October 15 of each year. The 2025 Convertible Notes will mature on April 15, 2025, unless earlier converted, redeemed or repurchased.
During the first quarter of Fiscal 2023, the Company entered into separate, privately negotiated exchange agreements with certain holders of the 2025 Convertible Notes. Under the terms of the exchange agreements, the holders exchanged $110.3 million in aggregate principal amount of 2025 Convertible Notes held by them for $133.3 million in cash. These exchanges resulted in aggregate pre-tax debt extinguishment charges of $24.6 million.
Prior to the close of business on the business day immediately preceding January 15, 2025, the 2025 Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the 2025 Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2025 Convertible Notes have an initial conversion rate of 4.5418 shares per $1,000 principal amount of 2025 Convertible Notes (equivalent to an initial conversion price of approximately $220.18 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50% over $166.17 per share, the last reported sale price of the Company’s common stock on April 13, 2020 (the pricing date of the offering) on the New York Stock Exchange. During the first quarter of Fiscal 2021, the Company made an irrevocable settlement election for any conversions of the 2025 Convertible Notes. Upon conversion, the Company will pay cash for the principal amount. For any excess above principal, the Company will deliver shares of its common stock. The Company was not permitted to redeem the 2025 Convertible Notes prior to April 15, 2023. From and after April 15, 2023, the Company is able to redeem for cash all or any portion of the 2025 Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130% of the conversion price for a specified period of time, at a redemption price equal to 100% of the principal aggregate amount of the 2025 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.
Holders of the 2025 Convertible Notes may require the Company to repurchase their 2025 Convertible Notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the 2025 Convertible Notes at a purchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their 2025 Convertible Notes in connection with such corporate event or during the relevant redemption period for such 2025 Convertible Notes. The effective interest rate is 2.8%.
2027 Convertible Notes
On September 12, 2023, the Company closed the issuance of approximately $297.1 million aggregate principal amount of its 1.25% Convertible Senior Notes due 2027 (2027 Convertible Notes) pursuant to separate, privately negotiated exchange and subscription agreements with a limited number of holders of its 2025 Convertible Notes and certain investors, in each case pursuant to exemptions from registration under the Securities Act of 1933. The Company exchanged approximately $241.2 million in aggregate principal amount of the 2025 Convertible Notes for approximately $255.0 million in aggregate principal amount of the 2027 Convertible Notes. This exchange resulted in aggregate pre-tax debt extinguishment charges of $13.6 million. The Company also issued approximately $42.1 million in aggregate principal amount of 2027 Convertible Notes in a private placement to certain investors. An aggregate of up to 1,422,568 shares of common stock may be issued upon conversion of the 2027 Convertible Notes, which number is subject to adjustment up to an aggregate of 1,911,372 shares following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, and which is also subject to certain anti-dilution adjustments.
The 2027 Convertible Notes will bear interest at a rate of 1.25% per year, payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2023. The 2027 Convertible Notes will mature on December 15, 2027, unless earlier converted, redeemed or repurchased.
Prior to the close of business on the business day immediately preceding September 15, 2027, the 2027 Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the 2027 Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2027 Convertible Notes have an initial conversion rate of 4.8560 shares per $1,000 principal amount of 2027 Convertible Notes (equivalent to an initial conversion price of approximately $205.93 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50% over $155.42 per share, the last reported sale price of the Company’s common stock on September 7, 2023 on The New York Stock Exchange. Upon conversion, the Company will pay cash up to the aggregate principal amount of 2027 Convertible Notes being converted, and pay (and deliver, if applicable) cash, shares of the Company’s common stock or a combination thereof, at its election, in respect of the remainder (if any) of the Company’s conversion obligation in excess of such aggregate principal amount. The Company will not be able to redeem the 2027 Convertible Notes prior to December 20, 2025. On or after December 20, 2025 and prior to the 21st scheduled trading day immediately preceding December 15, 2027, the Company will be able to redeem for cash all or any portion of the 2027 Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130% of the conversion price for a specified period of time, at a redemption price equal to 100% of the aggregate principal amount of the 2027 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.
Ifthe Company undergoes a fundamental change, subject to certain conditions, holders of the 2027 Convertible Notes may require the Company to repurchase for cash all or any portion of their 2027 New Convertible Notes. The fundamental change repurchase price will be 100% of the aggregate principal amount of the 2027 Convertible Notes to be repurchased plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The effective interest rate is 1.7%.
ABL Line of Credit
BCFWC and certain of its subsidiaries and holding companies are party to a Second Amended and Restated Credit Agreement (as amended, supplemented and otherwise modified, the ABL Line of Credit) that provides for $900.0 million of revolving commitments (subject to a borrowing base limitation) maturing on December 22, 2026, and, subject to the satisfaction of certain conditions, BCFWC can increase the aggregate amount of commitments up to $1,200 million. The interest rate margin applicable under the ABL Line of Credit is 1.125% to 1.375% in the case of a daily SOFR rate or a term SOFR rate (in each case, plus a credit spread adjustment of 0.10%), and 0.125% to 0.375% in the case of a prime rate, depending on the average daily availability of the lesser of (a) the total commitments or (b) the borrowing base. The ABL Line of Credit is collateralized by a first priority lien on BCFWC’s and each guarantor's inventory, receivables, bank accounts, and certain related assets and proceeds thereof (subject to certain exceptions), and a second priority lien on BCFWC’s and each guarantor's other assets and proceeds thereof (other than real estate and subject to certain exceptions).
On June 26, 2023, BCFWC entered into a Fifth Amendment to the Second Amended and Restated Credit Agreement, which increased the sublimit for letters of credit thereunder from $150 million to $250 million. The letter of credit sublimit was automatically reduced to $225 million on July 1, 2024, and will be automatically reduced to (i) $212.5 million on October 1, 2024, and (ii) $200 million on January 1, 2025. BCFWC and the agent may extend the foregoing date under clause (i), as long as the sublimit is reduced to $200 million no later than January 1, 2025.
At August 3, 2024, the Company had $816.1 million available under the ABL Line of Credit. There wereno borrowings under the ABL Line of Credit duringthe three and six month periods ended August 3, 2024.
At July 29, 2023, the Company had $818.7 million available under the ABL Line of Credit. There wereno borrowings under the ABL Line of Credit duringthe three and six month periods ended July 29, 2023.
- Derivative Instruments and Hedging Activities
The Company accounts for derivatives and hedging activities in accordance with ASC 815, “Derivatives and Hedging” (ASC 815). As required by ASC 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. In addition, to comply with the provisions of ASC 820, “Fair Value Measurements” (ASC 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with ASC 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting, because the Company has onlyone derivative. The Company classifies its derivative valuations in Level 2 of the fair value hierarchy.
On December 17, 2018, the Company entered into an interest rate swap, which hedged $450 million of the variable rate exposure under the Term Loan Facility at a rate of 2.72%. On June 24, 2021, the Company terminated this previous interest rate swap, and entered into a new interest rate swap, which hedges $450 million of the variable rate exposure on the Term Loan Facility at a blended rate of 2.19%, and is designated as a cash flow hedge.
During the second quarter of Fiscal 2023, the Company amended its interest rate swap to be based on SOFR rather than LIBOR, which resulted in an updated swap rate of 2.16%. This amendment was covered under the guidance in ASC Topic No. 848 "Reference Rate Reform" (ASC 848) and did not impact the hedge accounting relationship.
The amount of loss deferred for the previous interest rate swap was $26.9 million. The Company amortized this amount from accumulated other comprehensive income into interest expense over the original life of the previous interest rate swap, which had an original maturity date of December 29, 2023. The new interest rate swap had a liability fair value at inception of $26.9 million. The Company is accreting this amount into accumulated other comprehensive income as a benefit to interest expense over the life of the new interest rate swap, which has a maturity date of June 24, 2028.
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.
As of August 3, 2024, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk:
| Interest Rate Derivative | Number ofInstruments | Notional Aggregate Principal Amount | Interest Swap Rate | Maturity Date |
|---|---|---|---|---|
| Interest rate swap contract | One | $450.0 million | 2.16% | June 24, 2028 |
Tabular Disclosure
The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets:
| (in thousands) | ||||||
|---|---|---|---|---|---|---|
| Fair Values of Derivative Instruments | ||||||
| August 3, 2024 | February 3, 2024 | July 29, 2023 | ||||
| Derivatives Designated as Hedging Instruments | BalanceSheetLocation | FairValue | BalanceSheetLocation | FairValue | BalanceSheetLocation | FairValue |
| Interest rate swap contracts | Other assets | $20,090 | Other assets | $29,075 | Other assets | $36,134 |
The following table presents the unrealized gains and losses deferred to accumulated other comprehensive income resulting from the Company’s derivative financial instruments for each of the reporting periods.
| (in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Six Months Ended | |||
| Interest Rate Derivatives: | August 3, 2024 | July 29, 2023 | August 3, 2024 | July 29, 2023 |
| Unrealized (losses) gains, before taxes | $(12,338) | $11,560 | $(1,765) | $12,853 |
| Income tax expense (benefit) | 3,301 | (3,095) | 463 | (3,441) |
| Unrealized (losses) gains, net of taxes | $(9,037) | $8,465 | $(1,302) | $9,412 |
The following table presents information about the reclassification of gains and losses from accumulated other comprehensive income into earnings related to the Company’s derivative instruments for each of the reporting periods.
| (in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Six Months Ended | |||
| Component of Earnings: | August 3, 2024 | July 29, 2023 | August 3, 2024 | July 29, 2023 |
| Interest benefit | $(4,568) | $(1,610) | $(9,131) | $(2,739) |
| Income tax expense | 1,221 | 431 | 2,441 | 733 |
| Net reclassification into earnings | $(3,347) | $(1,179) | $(6,690) | $(2,006) |
The Company estimates that approximately $12.8 million will be reclassified from accumulated other comprehensive income as a reduction to interest expense during the next twelve months.
- Fair Value Measurements
The Company accounts for fair value measurements in accordance with ASC 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy:
Level 1: Quoted prices for identical assets or liabilities in active markets.
Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities.
The inputs into the determination of fair value require significant management judgment or estimation.
The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments.
Refer to Note 5, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate swap contract.
Financial Assets
The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of August 3, 2024, February 3, 2024 and July 29, 2023 are summarized below:
| (in thousands) | |||
|---|---|---|---|
| Fair Value Measurements at | |||
| August 3, | February 3, | July 29, | |
| 2024 | 2024 | 2023 | |
| Cash equivalents (including restricted cash equivalents) | $276,780 | $657,292 | $206,373 |
Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of ASC 820. The fair value of the Company’s long-lived assets is calculated using a discounted cash-flow model that used level 3 inputs. In calculating future cash flows, the Company makes estimates regarding future operating results and market rent rates, based on its experience and knowledge of market factors in which the retail location is located.
There wereno impairment charges on long-lived assets during the second quarter of Fiscal 2024. Impairment charges on long-lived assets were $2.3 million during the second quarter of Fiscal 2023, related to declines in revenue and operating results foreight stores, as well as lease asset impairment of $2.4 million related toone of those stores.
Impairment charges on long-lived assets were $8.2 million during the six months ended August 3, 2024, related to a sale-leaseback transaction atone owned store sold below net carrying value. Impairment charges on long-lived assets were $2.9 million during the six months ended July 29, 2023, related to declines in revenue and operating results forten stores, as well as lease asset impairment of $2.6 million related tothree of those stores. During the six months ended August 3, 2024 and the six months ended July 29, 2023, the assets impaired had a remaining carrying value after impairments of $9.8 million and $75.9 million, respectively.
Financial Liabilities
The fair values of the Company’s financial liabilities are summarized below:
| (in thousands) | ||||||
|---|---|---|---|---|---|---|
| August 3, 2024 | February 3, 2024 | July 29, 2023 | ||||
| PrincipalAmount | FairValue | PrincipalAmount | FairValue | PrincipalAmount | FairValue | |
| Term B-6 Loans | $932,573 | $934,904 | $937,379 | $934,450 | $942,187 | $939,831 |
| 2025 Convertible Notes | 156,155 | 187,870 | 156,155 | 169,384 | 397,375 | 429,860 |
| 2027 Convertible Notes | 297,069 | 402,196 | 297,069 | 342,384 | — | — |
| ABL Line of Credit (a) | — | — | — | — | — | — |
| Total debt (b) | $1,385,797 | $1,524,970 | $1,390,603 | $1,446,218 | $1,339,562 | $1,369,691 |
(a)
To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to its short term nature.
(b)
The table above excludes finance lease obligations, debt discount and deferred debt costs.
The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy, and are based on current market quotes received from inactive markets.
- Income Taxes
Income tax expense was $25.9 million duringthe second quarter of Fiscal 2024 compared with $11.1 million duringthe second quarter of Fiscal 2023. The effective tax rate for the second quarter of Fiscal 2024 was 26.0% compared with 26.4% duringthe second quarter of Fiscal 2023. The increase in income tax expense is due to higher pre-tax income. The decrease in tax rate is due to less tax expense from stock-based compensation.
Income tax expense was $57.0 million during the first half of Fiscal 2024 compared with $21.7 million during the first half of Fiscal 2023. The effective tax rate for the first half of Fiscal 2024 was 27.2% compared with 25.4% during the first half of Fiscal 2023. The increase in income tax expense and tax rate is due to higher pre-tax income and higher tax expense from stock based compensation, respectively.
Net deferred taxes are as follows:
| (in thousands) | |||
|---|---|---|---|
| August 3, | February 3, | July 29, | |
| 2024 | 2024 | 2023 | |
| Deferred tax asset | $2,190 | $2,436 | $2,925 |
| Deferred tax liability | 243,274 | 227,593 | 226,421 |
| Net deferred tax liability | $241,084 | $225,157 | $223,496 |
Net deferred tax assets relate to Puerto Rico deferred balances that have a future net benefit for tax purposes. Net deferred tax liabilities primarily relate to intangible assets and depreciation expense where the Company has a future obligation for tax purposes.
As of August 3, 2024, the Company had a deferred tax asset related to net operating losses of $5.4 million, inclusive of $5.1 million related to state net operating losses that expire at various dates between 2024 and 2041, as well as $0.3 million related to Puerto Rico net operating losses that will expire in 2025.
As of August 3, 2024, the Company had a deferred tax asset related to tax credit carry-forwards of $7.6 million, inclusive of $7.4 million of state tax credit carry-forwards, which will begin to expire in 2024, and $0.2 million of deferred tax assets recorded for Puerto Rico alternative minimum tax credits that have anindefinite life.
As of August 3, 2024, February 3, 2024 and July 29, 2023, valuation allowances amounted to $8.6 million, $11.4 million and $13.8 million, respectively, related to state and Puerto Rico net operating losses and state tax credit carry-forwards. The Company believes that it is more likely than not that this portion of state and Puerto Rico net operating losses and state tax credit carry-forwards will not be realized.
- Capital Stock
Treasury Stock
The Company accounts for treasury stock under the cost method.
Shares Used to Satisfy Tax Withholding
During the six month period ended August 3, 2024, the Company acquired 67,197 shares of common stock from employees for approximately $13.1 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock and restricted stock unit awards, which was recorded in the line item “Treasury stock, at cost” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows.
Share Repurchase Program
On February 16, 2022, the Company's Board of Directors authorized the repurchase of up to $500 million of common stock, which expired in February 2024.
On August 15, 2023, the Company's Board of Directors authorized the repurchase of up to an additional $500 million of common stock, which is authorized to be executed through August 2025.
During the six month period ended August 3, 2024, the Company repurchased 581,746 shares of common stock for $124.6 million under these repurchase programs, which was recorded in the line item “Treasury stock, at cost” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. As of August 3, 2024, the Company had$380.5 million remaining under its share repurchase authorization.
- Net Income Per Share
Basic net income per share is calculated by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is calculated by dividing net income by the weighted-average number of common shares and potentially dilutive securities outstanding during the period using the treasury stock method for the Company’s stock option, restricted stock and restricted stock unit awards, and the if-converted method for the Convertible Notes. The following table presents the computation of basic and diluted net income per share:
| (in thousands, except per share data) | ||||
|---|---|---|---|---|
| Three Months Ended | Six Months Ended | |||
| August 3, | July 29, | August 3, | July 29, | |
| 2024 | 2023 | 2024 | 2023 | |
| Basic net income per share | ||||
| Net income | $73,760 | $30,892 | $152,274 | $63,640 |
| Weighted average number of common shares – basic | 63,734 | 64,895 | 63,803 | 64,925 |
| Net income per common share – basic | $1.16 | $0.48 | $2.39 | $0.98 |
| Diluted net income per share | ||||
| Net income | $73,760 | $30,892 | $152,274 | $63,640 |
| Shares for basic and diluted net income per share: | ||||
| Weighted average number of common shares – basic | 63,734 | 64,895 | 63,803 | 64,925 |
| Assumed exercise of stock options and vesting of restricted stock | 431 | 144 | 421 | 216 |
| Assumed conversion of convertible debt | 163 | — | 60 | — |
| Weighted average number of common shares – diluted | 64,328 | 65,039 | 64,284 | 65,141 |
| Net income per common share – diluted | $1.15 | $0.47 | $2.37 | $0.98 |
Approximately 1,044,000 and 913,000 shares of the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and six month periods ended August 3, 2024, respectively, since their effect was anti-dilutive.
Approximately 1,821,000 and 1,282,000 shares related to the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and six month periods ended July 29, 2023, respectively, since their effect was anti-dilutive.
- Stock Based Compensation
As of August 3, 2024, there were 3,955,470 shares of common stock available for issuance under the Company’s 2022 Omnibus Incentive Plan.
Non-cash stock compensation expense is as follows:
| (in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Six Months Ended | |||
| August 3, | July 29, | August 3, | July 29, | |
| Type of Non-Cash Stock Compensation | 2024 | 2023 | 2024 | 2023 |
| Restricted stock unit grants (a) | $10,823 | $11,178 | $20,771 | $20,544 |
| Stock option grants (a) | 5,042 | 4,996 | 9,608 | 9,198 |
| Performance stock unit grants (a) | 8,914 | 3,251 | 13,506 | 6,405 |
| Total (b) | $24,779 | $19,425 | $43,885 | $36,147 |
(a)
Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income.
(b)
The amounts presented in the table above exclude taxes. Forthe three and six month periods ended August 3, 2024, the tax benefit related to the Company’s non-cash stock compensation was approximately $4.3 million and $7.9 million, respectively. For the three and six month periods ended July 29, 2023, the tax benefit related to the Company’s non-cash stock compensation was approximately $3.6 million and $6.9 million, respectively.
Stock Options
Stock option transactions duringthe six month period ended August 3, 2024 are summarized as follows:
| Number ofShares | WeightedAverageExercisePrice PerShare | |
|---|---|---|
| Options outstanding, February 3, 2024 | 1,356,258 | $197.90 |
| Options granted | 372,174 | 179.80 |
| Options exercised (a) | (145,649) | 163.83 |
| Options forfeited | (62,528) | 205.63 |
| Options outstanding, August 3, 2024 | 1,520,255 | 196.42 |
(a)
Options exercised duringthe six month period ended August 3, 2024 had a total intrinsic value of $9.5 million.
The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of August 3, 2024:
| Options | WeightedAverageRemainingContractualLife (Years) | WeightedAverageExercisePrice | Aggregate IntrinsicValue (in millions) | |
|---|---|---|---|---|
| Options vested and expected to vest | 1,520,255 | 7.4 | $196.42 | $91.8 |
| Options exercisable | 753,189 | 5.9 | $202.00 | $44.2 |
The fair value of each stock option granted duringthe six month period ended August 3, 2024 was estimated using the Black Scholes option pricing model using the following assumptions on a weighted average basis:
| Six Months Ended | |
|---|---|
| August 3, | |
| Risk-free interest rate | 4.69% |
| Expected volatility | 42% |
| Expected life (years) | 4.03 |
| Contractual life (years) | 10.0 |
| Expected dividend yield | 0% |
| Grant date fair value of options issued | $69.20 |
The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. To evaluate its volatility factor, the Company uses the historical volatility of its stock price over the expected life of the options. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. The expected life of the options was estimated using historical exercise rates.
Restricted Stock
Restricted stock transactions duringthe six month period ended August 3, 2024 are summarized as follows:
| Number ofShares | WeightedAverage GrantDate FairValue PerAward | |
|---|---|---|
| Non-vested awards outstanding, February 3, 2024 | 570,952 | $204.97 |
| Awards granted | 309,973 | 183.23 |
| Awards vested (a) | (156,746) | 224.77 |
| Awards forfeited | (41,846) | 195.52 |
| Non-vested awards outstanding, August 3, 2024 | 682,333 | 191.13 |
(a)
Restricted stock awards vested duringthe six month period ended August 3, 2024 had a total intrinsic value of $29.3 million.
The fair value of each share of restricted stock granted during the six month period ended August 3, 2024 was based upon the closing price of the Company’s common stock on the grant date.
Performance Stock Units
The Company grants performance-based restricted stock units to its senior executives. Vesting of the performance stock units granted in Fiscal 2021 is based on continued service and the achievement of pre-established adjusted EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over athree-year performance period. Vesting of the performance stock units granted in Fiscal 2022, Fiscal 2023, and Fiscal 2024 are based on continued service and the achievement of pre-established adjusted net income per share growth over a three-year performance period. Based on the Company’s achievement of these goals, each award may be earned up to 200% of the target award. In the event that actual performance is below threshold, no award will be made. Compensation costs recognized on the performance stock units are adjusted, as applicable, for performance above or below the target specified in the award.
Performance stock unit transactions duringthe six month period ended August 3, 2024 are summarized as follows:
| Number ofShares | WeightedAverage GrantDate FairValue PerAward | |
|---|---|---|
| Non-vested awards outstanding, February 3, 2024 | 226,917 | $217.29 |
| Awards granted | 124,624 | 185.10 |
| Awards vested (a) | (44,535) | 319.32 |
| Awards forfeited | (10,535) | 219.54 |
| Non-vested awards outstanding, August 3, 2024 | 296,471 | 188.35 |
(a)
Performance-based stock awards vested duringthe six month period ended August 3, 2024 had a total intrinsic value of $10.1 million.
- Commitments and Contingencies
Legal
In the course of business, the Company is party to class or collective actions alleging violations of federal and state wage and hour and other labor statutes, representative claims under the California Private Attorneys’ General Act and various other lawsuits and regulatory proceedings from time to time including, among others, commercial, product, employee, customer, intellectual property and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. While no assurance can be given as to the ultimate outcome of these matters, the Company believes that the final resolution of these actions will not have a material adverse effect on the Company’s results of operations, financial position, liquidity or capital resources.
Letters of Credit
The Company had letters of credit arrangements with various banks in the aggregate amount of $83.9 million, $75.8 million and $56.4 million as of August 3, 2024, February 3, 2024 and July 29, 2023, respectively. Among these arrangements, as of August 3, 2024, February 3, 2024 and July 29, 2023, the Company had letters of credit outstanding in the amount of $77.3 million, $75.8 million and $50.4 million, respectively, guaranteeing performance under various lease agreements, insurance contracts, and utility agreements. In addition, the Company had outstanding letters of credit arrangements in the amounts of $6.6 million and $6.0 million at August 3, 2024 and July 29, 2023, respectively, related to certain merchandising agreements, andnone at February 3, 2024. Based on the terms of the agreement governing the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $141.1 million, $174.2 million and $193.6 million as of August 3, 2024, February 3, 2024 and July 29, 2023, respectively.
Purchase Commitments
The Company had $1,798.0 million of purchase commitments related to goods that were not received as of August 3, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.